Abstract:OBJECTIVE:To search the role of Helicobacter pylori (H. pylori) in the progression of gastric carcinogenesis.METHODS:A cohort study was conducted by cluster randomized sampling in Linqu County, a rural area in Shandong Province in northeast China, where the mortality of gastric cancer (GC) is among the highest in the world. In 1989-1990, a gastroscopic examination and serum test was launched among subjects aged 35-64 from 14 randomized villages. Histological diagnosis of gastric mucosa and enzyme-linked immunosorbent assay was used to detect gastric lesions and anti-H. pylori of all participants. A repeated gastroscopic screening was offered to all cohort members in 1994 and 1999 respectively, and all the GC cases, regardless of natural ones or ones by gastroscopy, were registered in the follow-up periods.RESULTS:Fifty-eight cases of GC were identified in 2469 subjects during the 10-year follow-up, 44 were observed in 1603 H. pylori-positive persons (2.74%) and 14 in 866 H. pylori-negative persons (1.62%). The incidence rate of GC in H. pylori-positive is significantly higher than in H. pylori-negative (OR = 1.871, 95% CI: 1.012 - 3.459). There was no significant difference in the progression of gastric carcinogenesis between H. pylori-positive and H. pylori-negative (P > 0.05) among subjects with normal or superficial gastritis (SG) at baseline. In contrast, the significant difference was found in baseline chronic gastritis (CAG) group (P < 0.01), and the GC incidence rate in H. pylori-positive (7/615) is higher than in H. pylori-negative (0/470, P = 0.019). The difference of gastric lesions between H. pylori-positive and H. pylori-negative in subjects with intestinal metaplasia (IM) and dysplasia (DYS) at baseline was statistically significant after a 10-year follow-up (P < 0.05, P < 0.01, respectively), but the GC incidence rate in H. pylori-positive is similar to the rate in H. pylori-negative at the two groups (17/573 and 7/224 in IM group, P = 0.907; 19/368 and 7/122 in DYS group, P = 0.806).CONCLUSIONS:H. pylori is a key risk factor that prompts the transition from chronic atrophic gastritis to advanced precancerous lesions and influences the whole progression of precancerous gastric lesions. H. pylori, perhaps can not cause GC directly, increases the risk of GC in company with other carcinogens. H. pylori seemingly has no important effect on the development of GC when gastric mucosa is normal or superficial gastritis, but this conclusion is required to be further confirmed.

Helicobacter pylori infection in association with cell proliferation, apoptosis and prostaglandin E 2 levels

Distribution of H.pylori Antigens in Gastric Mucosa and Its Significance.

Relative Risk of Gastric Cancer Between Those with and Without Helicobacter Pylori Infection History in Japan

A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter Pylori Antibodies, and Gastric Cancer Risk.

H. pylori Infection and the Anatomic Distribution of Chronic Atrophic Gastritis in a Population at High Risk of Gastric Cancer

Helicobacter Pylori Infection is Associated with Gallstones: Epidemiological Survey in China.

Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

Helicobacter Pylori Infection and Gastric Cancer: Evidence from a Retrospective Cohort Study and Nested Case-Control Study in China.

Helicobacter Pyloriinfection and Esophageal Cancer Risk: an Updated Meta-Analysis

Relationship of Helicobacter Pylori Infection to the Expression of Proliferating Cell Nuclear Antigen and Apoptosis in Gastric Carcinoma

Abstract 2272: A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter Pylori Antibodies, and Gastric Cancer Risk

Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China

Effect of Helicobacter Pylori Infection on Gastric Epithelial Proliferation in Progression from Normal Mucosa to Gastriccarcinoma.

Relationship between precancerous gastric lesions and cell proliferation and apoptosis in a high-risk population

[Effect of Helicobacter Pylori on Gastric Mucosal Cell Proliferation in Gastritis].

Promoter Methylation of P16 Associated with Helicobacter Pylori Infection in Precancerous Gastric Lesions: A Population‐based Study

Helicobacter Pylori Blood Biomarkers and Gastric Cancer Survival in China

Apoptosis and proliferation in gastric epithelium due to Helicobacter pylori: an immunohistochemical and ultrastructural study

Helicobacter Pylori Antibody Responses and Evolution of Precancerous Gastric Lesions in a Chinese Population

[Helicobacter Pylori and the Progression of Gastric Cancer: a 10-Year Cohort Study].

Association of Helicobacter Pylori Infection and Serum Pepsinogen with Chronic Gastric Diseases and Gastric Cancer